S.P. Menting

Composition of Innate Lymphoid Cell Subsets in the Human Skin: Enrichment of NCR+ ILC3 in Lesional Skin and Blood of Psoriasis Patients

Marcel B. M. Teunissen, J. Marius Munneke, Jochem H. Bernink et al. · Journal of Investigative Dermatology · 2014 · 332 citations · Full text

Medicine, Dermatology, Immunology +17

Developing a Therapeutic Range of Adalimumab Serum Concentrations in Management of Psoriasis

S.P. Menting, Emma Coussens, Mieke F. Pouw et al. · JAMA Dermatology · 2015 · 101 citations · Full text

Medicine, Dermatology, Pharmacotherapy +14

Extent and Consequences of Antibody Formation Against Adalimumab in Patients With Psoriasis

S.P. Menting, P.P.M. van Lümig, Anna-Christa Q. de Vries et al. · JAMA Dermatology · 2013 · 81 citations · Full text

Life Sciences, Dermatology, Immunology +17

An increased risk of non‐melanoma skin cancer during <scp>TNF</scp>‐inhibitor treatment in psoriasis patients compared to rheumatoid arthritis patients probably relates to disease‐related factors

P.P.M. van Lümig, S.P. Menting, J. M. P. A. van den Reek et al. · Journal of the European Academy of Dermatology and Venereology · 2014 · 67 citations · Full text

Medicine, Clinical Sciences, Dermatology +16

Drug survival is not significantly different between biologics in patients with psoriasis vulgaris: a single‐centre database analysis

S.P. Menting, Amith Sitaram, H.M. Bonnerjee‐van der Stok et al. · British Journal of Dermatology · 2014 · 65 citations

Medicine, Dermatology, Pharmacotherapy +13